Summary Serum thyroxine was significantly higher in 59 patients with hepatocellular carcinoma than in normal subjects, patients with uncomplicated cirrhosis (48), or other primary tumours with or without hepatic metastases (50). Elevated thyroxine levels appeared attributable to high levels of thyroxine binding globulin which showed a positive linear correlation with serum thyroxine in all groups studied. Despite this hyperthyroxinaemia all patients appeared clinically euthyroid and, consistent with this, T3 was elevated in only one patient and the free thyroxine index was normal in all. Amongst a group of 25 cirrhotic patients who were followed-up for between 12 and 72 months, there was a striking dissociation between the TBG values of those destined to develop HCC and those who did not. In the former group TBG rose steadily with time whereas in the latter group levels remained stable, or, more often, fell. The rises in TBG occurred prior to any clinical signs of tumour development and may be one of the earliest serological changes to occur during carcinogenesis in the cirrhotic liver.
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Changes in the serum levels of thyroid hormones and their binding proteins in patients with cirrhosis are welldocumented (Chopra et al., 1974; Hepner & Chopra, 1979; Lumholtz et al., 1978; Nomura et al., 1975) . Most studies have shown a normal thyroxine (T4) level with impaired conversion to triiodothyronine (T3) resulting in low levels of T3 and high levels of reverse T3 (rT3). Despite this, clinical evidence of hypothyroidism is uncommon and direct measurement of free T4 (fT4) or the free thyroxine index has usually given normal values (Green et al., 1970; Liewendahl et al., 1983) . In contrast, hyperthyroxinaemia has been described in some patients with hepatocellular carcinoma (HCC), a frequent complication of long-standing cirrhosis (Gershengorn et al., 1976; Kalk et al., 1982; Nelson, 1979) . The hyperthyroxinaemia has been attributed to elevated levels of thyroxine binding globulin (TBG) but whether abnormalities of other thyroid binding proteins such as albumin and prealbumin are also involved has not been determined. There are also no data on how levels of TBG change before diagnosis of HCC or whether such changes are specific for HCC or occur generally in malignant disease.
In the present study we have measured the serum thyroid hormones together with their binding proteins in a large series of patients with HCC and various control groups including uncomplicated cirrhosis and other primary tumours with or without hepatic metastases. In healthy volunteers recruited from the ho6pital staff. None of the subjects studied was receiving drugs known to interfere with thyroid function. In all patients with HCC the serum samples studied were those collected at the time of diagnosis and prior to any treatment.
The stored serial sera (which had been frozen once and not previously thawed before the assay) came from patients included in a prospective study of the development of HCC in cirrhosis (Zaman et al., 1985) . These comprised 25 patients with histologically confirmed cirrhosis, none of whom at the time of the first available samples had any clinical or scanning evidence of HCC, or an elevated serum AFP level. In each individual case at least 2 and up to 4 serum samples were available over a follow-up period of between 1 and 6 years. Of these 25 patients, 10 ultimately developed HCC. Nine were male, with a mean age of 45 (range 33-59 years) and they represented all those patients with HCC in whom serial retrospective samples were available. The aetiology of the underlying cirrhosis (which had been diagnosed for a mean of 36 months (range 12-80 months)) was alcoholic 3, chronic active hepatitis 4, cryptogenic 2, and primary biliary cirrhosis 1.
The 15 patients who did not develop HCC were selected at random from the serum bank, the only criterion being that they should have serum samples available over a similar period to those who did develop HCC. Eight died following complications of cirrhosis other than HCC, and 7 were alive and without evidence of HCC development at the time of analysis. Ten were male, with a mean age of 49 (range 17-71 years). The aetiology of the underlying cirrhosis (diagnosed between 13 and 72 (mean 45)) months previously was alcoholic 6, chronic active hepatitis 3 and primary biliary cirrhosis 6. None of these patients was included in the first part of the study.
Triiodothyronine (T3), thyroid stimulating hormone (TSH) and AFP were measured by radioimmunoassay using commercially available kits (Amersham UK plc) as were TBG and T4 (Corning, Immophase). Serum albumin and prealbumin were measured by single radial immunodiffusion according to the method of Mancini et al.(1965) (Nor Partigen and M Partigen plates, Behring, UK). The normal ranges quoted are those given by the manufacturer and are based on several hundred normal subjects. Accuracy within the various methods was established by the manufacturers based on correlations with alternative methods of assay for each component. Correlation coefficients between the methods used here and the alternative procedures ranged from 0.912 (TBG immophase assay vs. nephelometry) to 0.976 (T4, immophase assay vs. solid phase RIA method). We included a small control group to confirm that the assays gave a comparable reference range in our hands. Duplicate assays were performed on each serum sample, the result being acceptable where the coefficient of variation was 5% or less. Data are presented as mean+s.d., and the MannWhitney 'U'-test used to assess the differences between the various groups. Correlations between TBG and T4 and T3 were assessed using logarithmic transformation of the TBG values on account of the skewed distribution of TBG values in the normal population (Gershengorn et al., 1976; Kalk et al., 1982) .
Results
Total serum T4 was elevated in 13 (22%) of those with HCC and in 3 patients (6%), to a minor degree, in the uncomplicated cirrhosis group. None of those with other primary malignant tumours had elevated T4 levels ( Figure  1) . Comparison of T4 levels in HCC patients showed no significant difference between those with and without cirrhosis. The free thyroxine index (T4/TBG ratio) was within the normal range (2.2-6.1) as were the T3 levels in all the cirrhotic and normal subjects and in all but 2 of the HCC patients in whom it was measured. TBG was at the upper limit of the normal range or elevated in all those with high T4 levels ( Figure 2 ) whereas serum albumin (mean 33+6.9, normal range 36-52gl-') and prealbumin (mean 120+59, normal range 250-300mgl-1) were normal or low. TBG levels were significantly higher in HCC patients than in those with uncomplicated cirrhosis (28±+11 g ml-compared to 20.4+7.6upgmlP-, P<0.01) and the control subjects (21.95+2.91pgml-P, P<0.01). Significant differences were also observed in respect of T4 values between HCC and uncomplicated cirrhotic patients and control subjects where T4 values were 126+57nmoll-1 in the HCC patients compared to 86. (0) represents patients with elevated T4 levels.
TBG levels were not distinguishable from those in whom levels were normal in respect of any of the clinical or pathological features recorded. Levels of TBG were linearly related to serum total T4 in patients with HCC (r=0.75, P<0.001), cirrhosis (r=0.65, P<0.0025) and, as expected, in normal subjects (r=0.50, P<0.0025) (Figure 3 ). Serum T3 levels showed a positive linear correlation with TBG in the 21 cirrhotic patients in whom it was measured (r=0.89, P<0.001) but not in the other two groups (r=0.4, P>0.05 for HCC, r=0.35, P>0.05 for normal subjects). Figure 4 ) and the rises c mainly within the normal range which was 4 patients. In contrast to those patients ultimately levels of TBG in those not developing HC (as seen in the 7 who eventually died) or (Figure 4) . Three cirrhotic patients (with P show no evidence of HCC development als( rising TBG levels but in only one di consecutive samples.
Eight of the 10 patients who developc serum AFP positive (>50ngml-1, a level in uncomplicated cirrhosis). Estimation of s in the same stored samples examined for 1 in 6 of these the rise in TBG occurred b months before the serum AFP exceeded 50 TBG levels were elevated 5 years before HCC and 2 years before AFP levels exce range. In the 3 remaining patients both prc taneously.
Discussion
Our figure of a 22% frequency for hyper patients with HCC is of the same order as Kalk et al. (1982) between 1 and 6 mean and standard deviation of the total T4 levels in the BG in the serum HCC patients in the two studies are also similar. The fact been a steadily that in the current study the mean T4 value in HCC patients r annum over the is significantly higher than in the control group, while in the igure 4). All had study of Kalk et al. (1982) they are not, may be related to t available serum the wider normal range. Using a reference based on our own bserved occurred small healthy control group, 50% of the HCC patients had exceeded in only elevated T4 levels. The demonstrated rise in TBG levels in the preclinical stage of the disease must also mean that the developing HCC, percentage of patients found with elevated levels is XC tended to fall dependent on the time of diagnosis.
remained stable
The clinical impression that the patients with hyper-'BC) who to date thyroxinaemia were euthyroid was supported by the T3 and o had episodes of T4/TBG levels which were not elevated. T3 levels in the d this occur in cirrhotic patients of the present series were normal rather than low as reported in the literature (Hepner & Chopra, ed HCC became 1979; Lumholtz et al., 1978) . This may reflect the generally seldom exceeded good condition of those patients who were selected from serum AFP levels cases of cirrhosis attending the out-patient clinic. rBG showed that
The finding that the total T4 level is linearly related to log etween 4 and 24 serum TBG over a wide range of T4 levels in both ngml-1. In one, uncomplicated cirrhosis and those with HCC suggests that the diagnosis of the hyperthyroxinaemia is attributable to an elevation of eded the normal TBG levels and not albumin or prealbumin which were )teins rose simuleither normal or low. In 2 other systematic studies of TBG in HCC, elevated levels were found in 10% of North American patients (Gershengorn et al., 1976) and 37% of South African blacks (Kalk et al., 1982) compared to our figure of 22%. These differences may again reflect differing definitions of the 'normal range'. The lower figure of 10% thyroxinaemia in may, as pointed out by Kalk et (Gartner et al., 1984) . In this regard it is interesting that with increasing T4 levels, the relative increase in TBG binding in both HCC and uncomplicated cirrhosis is higher than that seen in normal subjects (Figure 4 ). Thus at low concentrations of TBG T4 levels tend to be lower in the HCC and cirrhotic subjects whereas at high levels the reverse is true. Whether variant forms of TBG which are subject to allosteric modification occur in these two groups can only be established by purification and kinetic study of the species obtained from them.
The (Takamatsu & Refetoff, 1986) . These lished at the time differ in electrophoretic mobility, heat resistance, pH stability as well as in affinity for T3 and T4. It is possible that among this family, forms which display enhanced affinity for T4 and T3 may predominate in HCC and cirrhosis.
Although TBG is normally produced by the liver (Glinoer et al., 1976a,b ) the site of production in this situation is unknown and although most workers have considered the possibilities that either non-tumorous liver is stimulated to produce TBG by tumour or production by the tumour itself, there is also the possibility of production by a preneoplastic cell population. Recently two groups have demonstrated that HepG2, an established liver cell line derived from a child with a hepatoblastoma synthesises and secretes TBG which is immunologically identical to native human sera TBG (Bartalena et al., 1984; Murata et al., 1985) .
Whilst the degree of overlap between the TBG levels in cirrhotic patients with and without HCC means that the absolute level of TBG is not a clinically useful marker of HCC, the dissociation between rising levels in the former group and falling or stable levels in the latter may offer the possibility of a screening test for early HCC. This is particularly so as it appears that some changes can be detected whilst AFP levels are still normal. In view of the results obtained in this study, validation of such a test based on changes in TBG levels would be a long term study.
